Short-Term Human Prostate Primary Xenografts

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-2700PMID 14996731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significance of angiogenesis and microvascular invasion in renal cell carcinoma

  2009cited by this paper
• Angiogenesis Model of Human Prostate Cancer Vasculature and Short-Term Human Prostate Primary Xenografts : An in Vivo

  2004cited by this paper
• The Controls of Microvascular Survival

  2004cited by this paper
• Identification of endothelial cell genes by combined database mining and microarray analysis.

  2003cited by this paper
• Comparative and functional analyses of LYL1 loci establish marsupial sequences as a model for phylogenetic footprinting.

  2003cited by this paper
• Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

  2003cited by this paper
• Phenotypic Overlap Between Hematopoietic Cells with Suggested Angioblastic Potential and Vascular Endothelial Cells

  2002cited by this paper
• Gene expression pattern Expression of the chick vascular endothelial growth factor D gene during limb development

  2002cited by this paper
• Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry

  2002cited by this paper
• Targeting the prostate for destruction through a vascular address

  2002cited by this paper
• Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.

  2002cited by this paper
• Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

  2002cited by this paper
• Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

  2002cited by this paper
• Diversity in unity: The biochemical composition of the endothelial cell surface varies between the vascular beds

  2002cited by this paper
• Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration.

  2002influential reference
• Expression of the chick vascular endothelial growth factor D gene during limb development.

  2002cited by this paper
• Comparison of methods of microvascular staining and quantification in prostate carcinoma: Relevance to prognosis

  2002cited by this paper
• Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas

  2001cited by this paper
• Spontaneous adenocarcinoma mouse models for immunotherapy.

  2001cited by this paper
• Reactive stroma in prostate cancer progression.

  2001cited by this paper
• Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone.

  2001cited by this paper
• Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

  2001cited by this paper
• Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer.

  2001cited by this paper
• Angiogenesis and prostate cancer: identification of a molecular progression switch.

  2001cited by this paper
• Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer.

  2001cited by this paper
• Autochthonous mouse models for prostate cancer: past, present and future.

  2001cited by this paper
• The role of angiogenesis in prostate and other urologic cancers: a review.

  2001cited by this paper
• An address system in the vasculature of normal tissues and tumors.

  2000cited by this paper
• Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• Current Status Of Antiangiogenic Factors

  2000cited by this paper
• Use of nude mouse xenograft models in prostate cancer research

  2000cited by this paper
• WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma.

  2000cited by this paper
• Vascular endothelial growth factor expression and capillary architecture in high‐grade PIN and prostate cancer in untreated and androgen‐ablated patients

  2000cited by this paper
• Origins of circulating endothelial cells and endothelial outgrowth from blood.

  2000cited by this paper
• Independent prognostic importance of microvessel density in clinically localized prostate cancer.

  2000cited by this paper
• Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.

  2000cited by this paper
• Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids.

  1999cited by this paper
• Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

  1999cited by this paper
• Vascular endothelial growth factor (VEGF) and its receptors

  1999cited by this paper
• Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer.

  1999cited by this paper
• Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.

  1999cited by this paper
• A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

  1998cited by this paper
• What Might A Stromal Response Mean to Prostate Cancer Progression?

  1998cited by this paper
• Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.

  1998cited by this paper
• Microvessel density in prostate cancer: prognostic and therapeutic utility.

  1998cited by this paper
• Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts.

  1998cited by this paper
• Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer

  1998cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting.

  1998cited by this paper
• Lung cancer--management and outcome in Glasgow, 1991-92.

  1998cited by this paper
• Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis.

  1998cited by this paper
• Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival

  1998cited by this paper
• Model Systems of Prostate Cancer: Uses and Limitations

  1998cited by this paper
• Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Advances in angiogenesis research: relevance to urological oncology.

  1997cited by this paper
• Involvement of endothelial PECAM-1/CD31 in angiogenesis.

  1997influential reference
• Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer

  1997cited by this paper
• Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.

  1996cited by this paper
• Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells.

  1996cited by this paper
• Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts.

  1996cited by this paper
• Development of seven new human prostate tumor xenograft models and their histopathological characterization.

  1996cited by this paper
• Topography of neovascularity in human prostate carcinoma

  1995cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen.

  1995cited by this paper
• Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

  1994cited by this paper
• Experimental animal models for the study of therapeutic approaches in renal cell carcinoma.

  1994cited by this paper
• Tumor angiogenesis: review of current applications in tumor prognostication.

  1993cited by this paper
• Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections

  1993cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Cell turnover of capillaries.

  1967cited by this paper
• Cancer Research

  1902cited by this paper

• Targeted therapy for head and neck cancer: signaling pathways and clinical studies

  2023cites this paper
• A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

  2022cites this paper
• In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles.

  2021cites this paper
• Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry

  2018cites this paper
• Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field

  2018cites this paper
• First-Generation Tumor Xenografts: A Link Between Patient-Derived Xenograft Models and Clinical Disease

  2017cites this paper
• Patient-Derived Xenograft Models of Human Cancer

  2017cites this paper
• Patient-Derived Xenografts in Oncology

  2017cites this paper
• Towards best practice in establishing patient-derived xenografts

  2017cites this paper
• Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.

  2016cites this paper
• Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis

  2016cites this paper
• Advances in prostate cancer research models: From transgenic mice to tumor xenografting models

  2016cites this paper
• HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models

  2016cites this paper
• Saffron extract and its active constituents as preventative and/or treatment agents for prostate cancer using in vitro and in vivo models

  2016cites this paper
• Regulation of vascular endothelial growth factor in prostate cancer.

  2015influential citation
• Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer

  2015influential citation
• Proteomic Characterization of Head and Neck Cancer Patient–Derived Xenografts

  2015cites this paper
• Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities

  2015cites this paper
• Patient-Derived Xenografts as Pre-clinical Models of Response to Chemotherapy

  2014cites this paper
• One mouse, one patient paradigm: New avatars of personalized cancer therapy.

  2014cites this paper
• CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo.

  2014cites this paper
• Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening

  2014cites this paper
• A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone

  2014cites this paper
• Tumor Microenvironment in Human Tumor Xenografted Mouse Models

  2014cites this paper
• A tissue graft model of DNA damage response in the normal and malignant human prostate.

  2014cites this paper
• Origin of the vasculature supporting growth of primary patient tumor xenografts

  2013influential citation
• Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy

  2013cites this paper
• Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer

  2013cites this paper
• Murine Models of Prostate Cancer

  2013cites this paper
• Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cites this paper
• Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cites this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cites this paper
• Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma

  2012cites this paper
• Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cites this paper
• DNA damage recognition in the normal epithelium of human prostate and seminal vesicles

  2011cites this paper
• CD82/KAI1和HIF-1α在非小细胞肺癌中的表达及其与血管生成拟态的关系

  2011cites this paper
• Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients

  2011cites this paper
• Androgen deprivation induces rapid involution and recovery of human prostate vasculature.

  2011cites this paper
• Engineered human tumor xenografts with functional human vascular networks.

  2011cites this paper
• Metabolic , Endocrine and Genitourinary Pathobiology Tissue Slice Grafts An in Vivo Model of Human Prostate Androgen Signaling

  2010cites this paper
• Xenotransplantation of cryopreserved human ovarian tissue into murine back muscle.

  2010cites this paper
• Human prostate cancer heterotransplants: a review on this experimental model.

  2010cites this paper
• Human benign prostatic hyperplasia heterotransplants as an experimental model.

  2010cites this paper
• Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target*S

  2009cites this paper
• A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro.

  2009cites this paper
• Differential transplantability of human endothelial cells in colorectal cancer and renal cell carcinoma primary xenografts

  2009cites this paper
• Serially heterotransplanted human prostate tumours as an experimental model

  2009cites this paper
• Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell.

  2008cites this paper
• Morphological and functional evaluation of angiogenesis of a xenografted human sarcoma in nude mice

  2007cites this paper
• Human esophageal cancer endothelial cells increase tumor growth by incorporating with mouse endothelium.

  2007cites this paper
• Xenograft Models of Human Prostate Cancer

  2007cites this paper
• A Novel In Vivo Model of Human Hemangioma: Xenograft of Human Hemangioma Tissue on Nude Mice

  2007cites this paper
• Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line

  2006cites this paper
• The CXCR3 Targeting Chemokine CXCL11 Has Potent Antitumor Activity In Vivo Involving Attraction of CD8+ T Lymphocytes But Not Inhibition of Angiogenesis

  2005cites this paper
• Differential Transplantability of Tumor-Associated Stromal Cells

  2004cites this paper
• Advances in Brief Differential Transplantability of Tumor-Associated Stromal Cells

  2004cites this paper